Stroke/Cerebrovascular Disease News

• Poor Oral Health Tied to Worse Brain Health Attention to oral health may be a promising target for early interventions focused on improving brain health, a new study suggests.
  Medscape Medical News, January 09, 2024
• Eli Lilly Offers Obesity Drug Directly to Consumers Eli Lilly launched its direct-to-patient portal on Thursday, providing its obesity medicine (as well as diabetes and migraine drugs) direct to the consumer.
  WebMD Health News, January 05, 2024
• What Causes One of Stroke's Most Common Complications? Poststroke depression is one of the most common complications of stroke. Two new studies shed light on its mechanisms, paving the way for future treatment targets.
  Medscape Medical News, January 05, 2024
• Mortality Still Significant in High-Risk PE Despite Advances A new study showed continued high rates of in-hospital mortality in patients with high-risk PE, despite advances in treatment and creation of PE response teams.
  Medscape Medical News, January 05, 2024
• Long-term Clopidogrel Has Advantages After Coronary Stenting Clopidogrel after PCI was noninferior to aspirin for net adverse clinical events but superior in reducing secondary endpoints of stroke and MI, in 5-year STOPDAPT-2 results.
  Medscape Medical News, January 05, 2024
• Merck Seeks GLP-1 Drugs With Benefits Beyond Weight Loss - CEO Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.
  Reuters Health Information, January 04, 2024
• How 2023 Changed Care for Internists The past year brought major changes in preventive standards for anxiety, HIV, and RSV along with new guidelines for the treatment of atrial fibrillation.
  MDedge News, January 03, 2024
• Ascending Thoracic Aortic Aneurysms: A 'Silver Lining'? While they can be fatal upon rupture or dissection, ascending thoracic aortic aneurysms are also associated with apparent protection against atherosclerosis.
  Medscape Medical News, January 02, 2024
• Explainer-What Other Health Conditions Might Weight-loss Drugs Treat? Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.
  Reuters Health Information, January 02, 2024
• Window for Post-Stroke Antiplatelet Therapy Can Be Extended Dual antiplatelet therapy initiated up to 72 hours post-stroke cuts the risk for recurrent stroke but comes with increased bleeding risk, new data from the INSPIRES trial showed.
  Medscape Medical News, January 02, 2024
• New Stroke Prevention: Clopidogrel-Aspirin Within 72 Hours Groundbreaking data published in the NEJM questioned the commonly accepted 24-hour time window for administering dual antiplatelet therapy following a mild ischemic stroke.
  Medscape Medical News, January 01, 2024
• Warfarin Tied to Benefit After SAVR Treatment with warfarin early after bioprosthetic surgical aortic valve replacement is associated with lower mortality and thromboembolism risk but increased major bleeding events.
  Medscape Medical News, December 29, 2023
• Building a Toolkit for the Treatment of Acute Migraine Selecting a treatment plan to deal with acute migraine attacks is like putting together a toolkit of possible therapies which can be individualized for each patient, one expert said.
  Medscape Medical News, December 28, 2023
• AHA Names Top CVD Advances for 2023 Advances in stroke, a novel antihypertensive, and new evidence that diabetes drugs may offer CVD benefits for those without diabetes are among the top developments in 2023, on the AHA's annual list.
  Medscape Medical News, December 28, 2023
• Device-Detected Atrial High-Rate Episodes Tied to Mortality Atrial high-rate episodes are associated with more than twice the risk for mortality in patients with an implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator.
  Medscape Medical News, December 27, 2023
• Walking Fast May Help Prevent Type 2 Diabetes An analysis indicates that patients with fairly brisk walking are at a 24% lower risk for type 2 diabetes than those with easy or casual walking.
  Medscape Medical News, December 22, 2023
• No Impact of Race on Cardiovascular Risk Calculations A recent study adds to the growing body of evidence questioning the role of race-based stratification for specific clinical measures.
  Medscape Medical News, December 20, 2023
• Female Patients With PCI Benefit From Abbreviated DAPT Women undergoing percutaneous coronary intervention who receive abbreviated rather than standard dual antiplatelet therapy have similar outcomes to men despite higher baseline risk.
  Medscape Medical News, December 20, 2023
• Reducing CVD Morbidity and Mortality in Psoriasis and PsA Only a minority of patients with psoriatic disease know about their increased risks.
  MDedge News, December 20, 2023
• Patients Facing Death Are Choosing a Lifesaving Heart Device The HeartMate 3 is considered the safest mechanical heart pump of its kind, but a federal database has more than 4500 reports in which the medical device may have caused a patient's death.
  KFF Health News, December 20, 2023
• Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
  Medscape Medical News, December 04, 2023
• ACC/AHA Issue Updated Atrial Fibrillation Guideline The new guideline proposes a new way to classify AF, emphasizes the importance of early rhythm control and lifestyle modification, and gives catheter ablation a Class 1 indication.
  Medscape Medical News, November 30, 2023
• Ohio Group Scores Record Hypertension Control Rates Artificial intelligence is vastly improving blood pressure control at one Midwestern primary care practice. Could your group do the same?
  Medscape Medical News, November 30, 2023
• TCT 2023 Transapical Valve Replacement Relieves Mitral Regurgitation Transapical mitral valve replacement by catheter eliminated mitral regurgitation and improved hemodynamics in a frail high-risk population, results of the SUMMIT trial show.
  Medscape Medical News, November 30, 2023
• Less Severe Strokes With LAA Closure vs DOAC in AF? Atrial fibrillation treated with left atrial appendage closure was associated with ischemic strokes that were less severe than those among similar patients treated with direct oral anticoagulation.
  Medscape Medical News, November 27, 2023
• Perceived Racism Among Black Women a Stroke Risk Factor? The high burden of interpersonal racism experienced by Black women in the US may contribute to racial disparities in stroke incidence, new research suggests.
  Medscape Medical News, November 21, 2023
• PREVENT: AHA's New Risk Calculator Incorporates CKM Health The new cardiovascular disease risk equations start at age 30, include measures of kidney and metabolic health, add heart failure, and remove race from the equations.
  Medscape Medical News, November 20, 2023
• AHA 2023 Single Injection Reduces Blood Pressure for 6 Months The RNA interference therapeutic targeting synthesis of angiotensinogen lowered BP in adults with mild to moderate hypertension for up to 6 months after one dose in the phase 2 KARDIA-1 study.
  Medscape Medical News, November 20, 2023
• Asundexian Phase 3 AF Study Halted for Lack of Efficacy The phase 3 OCEANIC-AF trial of the factor XI inhibitor asundexian (Bayer) has been stopped early owing to inferior efficacy vs apixaban in preventing stroke and systemic embolism in patients with AF.
  Medscape Medical News, November 20, 2023
• Hourly Air Pollution Exposure: A Risk Factor for Stroke Daily exposure to air pollutants has been linked to stroke. A new study investigates the link between hourly exposure to air pollutants and emergency stroke admission shortly after exposure.
  Medscape Medical News, November 17, 2023
• Women Stroke Survivors Fear Disparity in Emergency Care Women with a history of stroke voice their experiences with emergency care, reflecting the challenges they face and the urgent necessity for more equitable healthcare delivery.
  Medscape Medical News, November 16, 2023
• AHA 2023 More Evidence of Better Outcomes With 120 mm Hg BP Target Intensive lowering of blood pressure to a systolic target < 120 mm Hg reduced cardiovascular events among high-risk individuals by 12% vs a target < 140 mm Hg in the ESPRIT trial.
  Medscape Medical News, November 16, 2023
• AF Linked to Dementia, Especially Before Age 65 Years Atrial fibrillation is linked to an increased risk for dementia, particularly when diagnosed before age 65 years, a large population-based study shows.
  Medscape Medical News, November 13, 2023
• AHA 2023 Impressive Bleeding Profile With Factor XI Inhibitor in AF Further details from the phase 2b AZALEA trial of the factor XI inhibitor abelacimab show significant reductions in major and clinically relevant nonmajor bleeding vs rivaroxaban for patients with AF.
  Medscape Medical News, November 13, 2023
• Mobile Stroke Units Tied to Better Outcomes vs EMS Mobile stroke units equipped with clot busting medications, CT machines, and video connections to a physician are linked to better patient outcomes, including stroke avoidance, vs traditional EMS.
  Medscape Medical News, November 13, 2023
• ACR 2023 Pregnancy in Rheumatic Disease Quadruples CVE Risk Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than did pregnant individuals without these conditions.
  Medscape Medical News, November 12, 2023
• AHA 2023 Dropping Aspirin Cuts Bleeding in LVAD Patients A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk.
  MDedge News, November 12, 2023
• AHA 2023 Blood Pressure Lowering Reduces Dementia Risk Blood Pressure Lowering Reduces Dementia Risk
  Medscape Medical News, November 12, 2023
• AHA 2023 Apixaban Cuts Stroke but Ups Bleeding in Subclinical AF Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.
  Medscape Medical News, November 12, 2023
• AHA 2023 Semaglutide 'A New Pathway' to CVD Risk Reduction: SELECT The weight loss drug showed a consistent reduction in major cardiovascular events over a 3-year follow up in patients with a history of heart disease who were overweight or obese.
  Medscape Medical News, November 11, 2023